Biotech Values

[jq1234]

Small biotechs are going to raise money, it is way of life for them. The question is always when and how much at what term. 110 is the one that is going to cost money, 011 is not costing much from now on because the trial is just follow up for survival at this point. Other trials are small. Hopefully they'll raise some around 011 data in Dec, or partnership at that point.